CBD For Lennox-Gastaut Syndrome: A Promising Option
View the original article about CBD For Lennox-Gastaut Syndrome at CBD vs FDA.
There has been a growing interest in the research of CBD’s potential in treating Lennox-Gastaut Syndrome, which is a form of epilepsy. Keep reading to find out more.
Lennox-Gastaut syndrome (LGS) is a rare and severe form of epilepsy that typically appears in children between the ages of 3 and 5 years old. LGS is often resistant to traditional epilepsy treatments, making it a challenging condition to manage.
In recent years, CBD has gained attention as a potential treatment for epilepsy, including Lennox-Gastaut syndrome.
One study published in the New England Journal of Medicine found that CBD was effective in reducing the frequency and severity of seizures in children with LGS. Participants in the study received a CBD-based medication called Epidiolex, which is specifically formulated for the treatment of epilepsy. The study found that Epidiolex was able to significantly reduce the number of seizures experienced by participants, with many seeing a 50% or greater reduction in seizures.
Another study published in the Journal of Child Neurology also found that CBD was effective in reducing seizures in children with LGS. Participants in the study received a CBD-based medication called CBD-enriched oil, and researchers found that it was able to significantly reduce the number of seizures experienced by participants.
While CBD has been shown to be effective in reducing seizures in children with LGS, it is important to note that it is not without potential side effects. Common side effects of CBD may include drowsiness, diarrhea, and changes in appetite. It is important to talk to a healthcare professional about the potential risks and benefits of using CBD for LGS.
It is also important to note that CBD is not yet approved by the FDA for the treatment of LGS or any other medical condition. While it has shown promise in early studies, more research is needed to fully understand the safety and effectiveness of CBD for the treatment of LGS.
Lennox-Gastaut syndrome is a severe and challenging form of epilepsy that can be difficult to manage with traditional treatments. However, emerging research suggests that CBD may be a promising option for the treatment of LGS. While more research is needed to fully understand the safety and effectiveness of CBD for LGS, early studies have shown that it may be able to significantly reduce the frequency and severity of seizures in children with this condition.
Learn more about CBD Treatment at CBD vs FDA.
Advertising disclosure: We may receive compensation for some of the links in our stories. Thank you for supporting LA Weekly and our advertisers.